Z5. COVID-19 Complications, co-infections, and clinical outcomes
Poster Session: COVID-19: Complications, Coinfections and Clinical Outcomes
Mark Berry, PhD (he/him/his)
Director, epidemiology
Gilead Sciences, Inc.
Foster City, California, United States
Valentina Shvachko, MS
Gilead Sciences, Inc.
Foster City, California, United States
Amanda Kong, DrPH
Aetion
New York, New York, United States
Rohan Shah, BS
Aetion, Inc
New York, New York, United States
Gina Brown, MD
Gilead Sciences
Foster City, California, United States
Anand Chokkalingam, PhD
Clinical Research
Gilead
Foster City, California, United States